Abstract
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic protein that catalyzes metabolic detoxification of quinones and protects cells against redox cycling and oxidative stress. NQO1-null mice deficient in NQO1 protein showed increased sensitivity to 7,12-dimethylbenz(a)anthracene– and benzo(a)pyrene-induced skin carcinogenesis. In the present studies, we show that benzo(a)pyrene metabolite benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide and not benzo(a)pyrene quinones contributed to increased benzo(a) pyrene-induced skin tumors in NQO1-null mice. An analysis of untreated skin revealed an altered intracellular redox state due to accumulation of NADH and reduced levels of NAD/NADH in NQO1-null mice as compared with wild-type mice. Treatment with benzo(a)pyrene failed to significantly increase p53 and apoptosis in the skin of NQO1-null mice when compared with wild-type mice. These results led to the conclusion that altered intracellular redox state along with lack of induction of p53 and decreased apoptosis plays a significant role in increased sensitivity of NQO1-null mice to benzo(a)pyrene-induced skin cancer.
- NQO1
- Lack of induction of p53
- Chemical Carcinogenesis
- Prevention
- Melanoma/skin cancers
Footnotes
-
Note: A. Gaikwad is presently in Molecular Therapeutics, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
R. Barrios is presently in Methodist Hospital, Houston, TX 77030.
D. J. Long II is presently in Department of Biology, San Jacinto College, Pasadena, TX 77504.
M. Paquet is presently in Department of Veterinary Medicine, M.D. Anderson Cancer Center, Houston, TX 77030.
C. Brayton is presently in Comparative Medicine, John Hopkins, Baltimore, MD 21205.
- Received September 1, 2004.
- Revision received November 30, 2004.
- Accepted January 5, 2005.
- ©2005 American Association for Cancer Research.












